# iShares S&P 500 Health Care Sector UCITS ETF (IHCU) **Source:** https://fundology.uk/fund/ihcu · ISIN IE00B43HR379 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 30/09/2026, IHCU (iShares S&P 500 Health Care Sector UCITS ETF, ISIN IE00B43HR379) closed at £10.38 on the London Stock Exchange. Its ongoing charge is 0.15% a year (about £15 on £10,000). Over the five years to 30/09/2026 its total return was +45.9%, or +14.1% after UK CPIH inflation. ## Summary iShares S&P 500 Health Care Sector UCITS ETF is an exchange-traded fund (ETF) from iShares, launched in 2015. It tracks the S&P 500 CAPPED 35/20 HEALTH CARE NTR — about 500 of the largest companies listed in the US. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.15% a year — about £15 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£10.38** (30/09/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | IHCU | | ISIN | IE00B43HR379 | | Category | Healthcare | | Type | ETF | | Provider | iShares | | Tracks | S&P 500 CAPPED 35/20 HEALTH CARE NTR | | Income | Accumulating | | Ongoing charge | 0.15% a year (£15 per £10,000) | | Fund size | £1.8bn | | Launched | 2015 | | Domicile | Ireland | ## Past returns (periods to 30/09/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +29.21% | +25.15% | income reinvested | | 3 years | +27.29% | +14.87% | income reinvested | | 5 years | +45.93% | +14.07% | income reinvested | Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published. ## Calendar-year returns Calendar-year returns of iShares S&P 500 Health Care Sector UCITS ETF in pounds (price, with income reinvested in the fund): 2022 +9.0%, 2023 −3.9%, 2024 +4.7%, 2025 +5.2%; 2026 to 30/09/2026 +13.0%. Returns of iShares S&P 500 Health Care Sector UCITS ETF in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +29.1%; to 30/09/2025: −11.3%; to 30/09/2024: +9.8%; to 30/09/2023: −2.9%; to 30/09/2022: +16.3%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | +9.0% | -0.2% | Price | | 2023 | -3.9% | -7.7% | Price | | 2024 | +4.7% | +1.1% | Price | | 2025 | +5.2% | +1.5% | Price | | 2026 to 30/09/2026 | +13.0% | +9.8% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 16.62% | -10.70% | | 3 years | 14.40% | -19.00% | | 5 years | 13.99% | -19.00% | ## Largest fall Volatility of iShares S&P 500 Health Care Sector UCITS ETF in pounds, annualised from weekly returns to 30/09/2026: 16.6% over 1 year, 14.4% over 3 years, 14.0% over 5 years. Largest fall in the price of iShares S&P 500 Health Care Sector UCITS ETF since October 2021, in pounds: −19.0% from 31/01/2025 to 23/05/2025. The lowest 12-month return of iShares S&P 500 Health Care Sector UCITS ETF in pounds (price, with income reinvested in the fund) since January 2021 was −16.8% (12 months to 08/08/2025); the highest was +30.1% (12 months to 08/04/2022). On 30/09/2026 the price of iShares S&P 500 Health Care Sector UCITS ETF was at its highest weekly close since October 2021, in pounds. ## Charges compared with similar funds Ongoing charge of iShares S&P 500 Health Care Sector UCITS ETF 0.15% a year, as of 01/10/2026: 14 of the 17 other healthcare funds charge more, 1 the same and 2 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.15%** per year - ISA eligible: yes - SIPP eligible: yes ## Top holdings Largest positions (as of 29/09/2026): | Holding | Weight | |---|---| | Eli Lilly and | 15.29% | | Johnson & Johnson | 10.40% | | AbbVie | 7.50% | | Merck | 5.94% | | Unitedhealth Group | 5.43% | | Thermo Fisher Scientific | 4.05% | | Amgen | 3.70% | | Gilead Sciences | 3.03% | | Abbott Laboratories | 2.82% | | Pfizer | 2.64% | ## Where it invests Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed. ### By sector As published by iShares, as of 29/09/2026. | Sector | Weight | |---|---| | Pharmaceuticals | 37.1% | | Biotechnology | 19.7% | | Health Care Equipment | 14.3% | | Life Sciences Tools & Services | 10.6% | | Managed Health Care | 8.0% | | Health Care Services | 3.9% | | Health Care Distributors | 3.5% | | Health Care Facilities | 1.4% | | Other sectors | 1.4% | ### By type of asset Added up from the holdings iShares publishes, as of 29/09/2026. | Type of asset | Weight | |---|---| | Equity | 99.9% | | Cash and money market | 0.1% | All 62 holdings: https://fundology.uk/fund/ihcu/holdings --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.